Loss of ovarian function and the risk of ovarian cancer.
about
Fancf-deficient mice are prone to develop ovarian tumoursCharacterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatment7,12-dimethylbenz[a]anthracene induces sertoli-leydig-cell tumors in the follicle-depleted ovaries of mice treated with 4-vinylcyclohexene diepoxide.Repeated ovarian stimulation does not affect the expression level of proteins involved in cell cycle control in mouse ovaries and fallopian tubes.Ficus umbellata Vahl. (Moraceae) Stem Bark Extracts Exert Antitumor Activities In Vitro and In Vivo.Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity.4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity.Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.Ovarian surface epitheliectomy in the non-human primate: continued cyclic ovarian function and limited epithelial replacement.Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice.Autoantibodies to mesothelin in infertility.Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor.Gonad morphogenesis in vertebrates: divergent means to a convergent endConsequences of RAS and MAPK activation in the ovary: the good, the bad and the ugly.7,12-dimethylbenz[a]anthracene-induced malignancies in a mouse model of menopause.FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.Anti-HE4 antibodies in infertile women and women with ovarian cancer.Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion.Modulation of gene expression in ovarian cancer by active and repressive histone marks.Development of a mouse model of menopausal ovarian cancer.Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection.Ultraminiature optical design for multispectral fluorescence imaging endoscopes.Tubal origin of ovarian endometriosis.
P2860
Q28247935-46FE4741-BB1B-43FD-8B23-307C4868C6D2Q28537709-4041CFC1-F882-454E-B58F-15F447CA4509Q33676655-939AAE33-0AD1-4FA9-9AA8-EF91F01EF159Q33722020-C9E59253-B9E7-43D1-A29B-8A459C1A763BQ33838317-E08266CE-5EC4-420B-907D-1BCE3C68B7DEQ34116325-D3D3D924-4616-4C63-B862-B7DC6FE7FD2EQ34118988-8E5EEEE3-4F72-433C-8B7F-48861B8CAA56Q34246525-DF3979F1-6818-44CE-AFA2-20B34CC07096Q34764768-4013D6BD-714A-4DA5-9C9E-CD5BA6213B31Q34987376-B0E1153F-2012-4ACE-8945-4D843B56132BQ35024049-93EC4D8E-20AC-4397-B9C6-2BEB0945E1D8Q35832948-9F523491-ABDD-4E2D-A7FD-BE9741E5DB67Q35855100-57DFA10A-EF27-49C4-84CA-9FFBCE51E825Q35866434-E206C06D-B8F1-4B0F-8AC4-EC5F852B4F22Q35892495-AD89D0B9-0959-4EB8-9174-0E3EB690934CQ36595420-D7E093A4-B8C0-46B8-B3EA-F24D0C9AE833Q36893369-F8D17BA7-DB61-44F5-8DA1-9E9F876483BBQ37107033-027AB798-550E-41A8-B4B7-FFD9661BAAD2Q37179374-5AD42F3E-F2CC-4C5D-AA50-D6F5DD74EA53Q37224153-6CD3915A-022F-48EA-B917-4BB3635011BAQ37267909-E8AF7AB0-372D-432B-B7C9-3E911FE42F0DQ37962015-7DE6E51C-5085-4FAB-9A90-575401743102Q38195046-F050C11A-B773-4C2C-BF6A-A2D1118E6A2DQ38409073-9A39A7F0-C1CA-4CC2-9723-BB0D15A509EFQ50182388-375175B3-3EFF-4F98-A24E-169C1692FB9EQ54229188-F3136773-B219-4AEE-BA65-B4B3CC5DFD3C
P2860
Loss of ovarian function and the risk of ovarian cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Loss of ovarian function and the risk of ovarian cancer.
@ast
Loss of ovarian function and the risk of ovarian cancer.
@en
type
label
Loss of ovarian function and the risk of ovarian cancer.
@ast
Loss of ovarian function and the risk of ovarian cancer.
@en
prefLabel
Loss of ovarian function and the risk of ovarian cancer.
@ast
Loss of ovarian function and the risk of ovarian cancer.
@en
P1476
Loss of ovarian function and the risk of ovarian cancer.
@en
P2093
Barbara C Vanderhyden
P2860
P2888
P304
P356
10.1007/S00441-005-1100-1
P577
2005-10-01T00:00:00Z